Matinas BioPharma (MTNB) Files $200M Mixed Shelf streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The National Lipid Association Scientific Sessions will be held today to Sunday and will spotlight statements on nutrition in adults with dyslipidemia, include sessions on the integration of lipid guidelines in clinical practice and more.Healio | Cardiology Today spoke with NLA President Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN, chief scientist at Midwest Biomedical Research and adjunct
Operator: Greetings and welcome to the Matinas BioPharma First Quarter 2023 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Update on May 10, 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,100,000 shares, a decrease of 9.8% from the March 31st total of 1,220,000 shares. Based on an average daily volume of 368,600 shares, […]